Logo
x

Search category

Subscribe Now

All Posts by Date

METiS Entered into a License Agreement with Voronoi to Develop and Commercialize Pan-RAF Inhibitor Program

METiS Entered into a License Agreement with Voronoi to Develop and Commercialize Pan-RAF Inhibitor Program

  • September 13, 2022
ILAP and its nuance vs PRIME since BREXIT

ILAP and its nuance vs PRIME since BREXIT

  • September 13, 2022
CStone Reports NMPA Acceptance of sNDA and Granted Priority Review for Sugemalimab to treat Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma

CStone Reports NMPA Acceptance of sNDA and Granted Priority Review for Sugemalimab to treat Relapsed or Refractory Extranodal Natu...

  • September 13, 2022
Regeneron Seeks Expedited Trial for Aflibercept Biosimilar

Regeneron Seeks Expedited Trial for Aflibercept Biosimilar

  • September 13, 2022
Novo Nordisk Collaborated with Microsoft to Advance Drug Discovery and Development Using AI

Novo Nordisk Collaborated with Microsoft to Advance Drug Discovery and Development Using AI

  • September 13, 2022
Pfizer and BioNTech Receive EMA's CHMP Positive Opinion Recommending Conditional Marketing Authorization for Omicron BA.4/BA.5 Bivalent Booster Vaccine

Pfizer and BioNTech Receive EMA's CHMP Positive Opinion Recommending Conditional Marketing Authorization for Omicron BA.4/BA.5 Biv...

  • September 13, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.